By Leigh Dayton 22 November 2021
It was a challenge that had to be met. “This November, walk or run 4km every day and raise funds to support women living with ovarian cancer,” proposed Ovarian Cancer Australia (OCA), a not-for-profit organisation which supports women […]
‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells
Cellular immunotherapy is revolutionizing cancer treatment. However, treatments created from each patient’s cells are complex, costly, and limited by the number and quality of killer T cells that can be isolated from and expanded for re-infusion into each patient.
In this […]
By Leigh Dayton
7 October 2021
According to Cartherics CEO Alan Trounson, taking ideas from the laboratory to the marketplace is a “long and tortuous process”. First-hand experience goes far towards identifying and navigating the hurdles of research translation.
And experience – from pioneering work in IVF and embryonic stem cell science […]
By Leigh Dayton
9 August 2021
Cartherics is pleased to announce that CEO Alan Trounson has been congratulated by the National Library of Australia for his recognition on this year’s Queen’s Birthday Honours List.
In recognition of his “distinguished service to medical science, and to in vitro fertilisation and stem cell technologies” Trounson was appointed an […]
By Leigh Dayton
22 July 2021
Cartherics is delighted to announce that it is a sponsor of the Australia and New Zealand Society of Cell and Developmental Biology’s Victorian State Conference. The highly regarded one-day event is booked for 26 August at the University of Melbourne.
Cartherics CEO Alan Trounson welcomes the opportunity to support the meeting.
“It is […]
Cartherics Pty Ltd and the Australian Regenerative Medicine Institute (ARMI), including commercialisation initiative CCRM Australia, announced agreements for closer cooperation and collaboration today.
“Cartherics affiliation with ARMI is an important step in our development and will embed industry and academic excellence in regenerative medicine and translation to clinical medicine in cancer,” said Prof Alan Trounson, Cartherics […]
Melbourne, Australia and Seoul, South Korea
28 June 2021
Cartherics Pty Ltd (“Cartherics”) and ToolGen, Inc. (“ToolGen”) announced today that they have entered into a commercial licence agreement.
Under the agreement, Cartherics obtains […]
By Leigh Dayton
11 June 2021
Alan Trounson joined a day-long discussion on advances in regenerative medicine. The virtual event brought together the world’s leading experts.
At the session on emerging immuno-oncology, Trounson told delegates that Cartherics believes its novel CAR-T and CAR-NK cells have great potential […]
By Leigh Dayton
31 May 2021
As a youngster Noam Amitay and his sister and three brothers lived in the “kids’ house” at a […]
By Heather Hawkins
24 May 2021
Even today – and it’s been 14 years since diagnosis – they still evoke a very raw and deeply emotional response. It was the first time I’d faced the undeniable fact […]
